| Janet Marie Christman, NP | |
|
3100 Professional Dr, Ann Arbor, MI 48104-5131 | |
| (734) 973-0710 | |
| (734) 973-0595 |
| Full Name | Janet Marie Christman |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Women's Health |
| Location | 3100 Professional Dr, Ann Arbor, Michigan |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1982851374 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 4704198938 (Michigan) | Secondary |
| 363LW0102X | Nurse Practitioner - Women's Health | 4704198938 (Michigan) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Janet Marie Christman, NP Po Box 3673, Ann Arbor, MI 48106-3673 Ph: (734) 973-0710 | Janet Marie Christman, NP 3100 Professional Dr, Ann Arbor, MI 48104-5131 Ph: (734) 973-0710 |
News Archive
Clinical inertia does not allow healthcare professionals to diagnose cholesterol problems in the 65.3% of cases. The results warn of the need to adopt a more proactive attitude towards a complete dyslipidemia diagnosis in routine clinical practice, especially if it is taken into account that it is an illness related to an increase of cardiovascular risk.
The UK has failed to match the gains made in reducing deaths among children and young adults by 17 other high-income countries in the European Union, Australia, Canada, and Norway (EU15+) in the 38 years since 1970.
Researchers, led by Carnegie Mellon University President Subra Suresh and MIT Principal Research Scientist Ming Dao, have created a new computer model that shows how tiny slits in the spleen prevent old, diseased or misshapen red blood cells from re-entering the bloodstream.
InSite Vision Incorporated and Senju Pharmaceutical Co., Ltd. today announced that they have entered into a collaboration and license agreement to develop and market InSite's azithromycin ophthalmic solution using DuraSite® including AzaSite® 1% and AzaSite XtraTM 2% ocular antibiotics in Japan. Senju has agreed to pay InSite an upfront license fee, additional development milestones fees, and a percentage royalty on net sales.
› Verified 1 days ago